Core Scientific Shareholders Reject $9B CoreWeave Deal

1 min read
Source: Investor's Business Daily
Core Scientific Shareholders Reject $9B CoreWeave Deal
Photo: Investor's Business Daily
TL;DR

CoreWeave terminated its $9 billion all-stock merger with Core Scientific after shareholders rejected the deal, leading to a decline in CoreWeave's stock. The deal's rejection reflects ongoing investor caution despite the growing AI cloud market, with CoreWeave continuing to operate its data centers and serve major clients like OpenAI and Microsoft.

Share this article

Want the full story? Read the original reporting

Read on Investor's Business Daily